The long term objective of this project is to determine mechanisms by which TCDD causes reproductive and developmental toxicity in animals so as to better understand the potential hazards TCDD and related compounds pose to human health. Previous data from this laboratory have shown that the rat male reproductive system is exceptionally sensitive to maternal TCDD exposure. Effects include impaired prostate growth, reduced sperm numbers, and demasculinized sexual behaviors. The proposed project will continue to elucidate mechanisms for the male reproductive effects as well as extend the assessment of potential TCDD adverse effects and mechanisms to the female reproductive system and preimplantation embryo. Because the prostate is so vulnerable, effects on prostate budding, cell differentiation and proliferation, androgen metabolism, and mRNA abundance will be determined. Because TCDD decreases ejaculated sperm numbers far more than it impairs spermatogenesis, sperm release in urine and spontaneous ejaculates, and excurrent duct sperm and fluid transit will be assessed. A major emphasis of the proposed project is to evaluate the potential role of the aryl hydrocarbon receptor (AhR) and AhR nuclear translocator (ARNT) in both normal reproductive system development and TCDD-mediated reproductive and developmental toxicity. Because TCDD might act directly on reproductive organs, the ontogeny and distribution of AhR and ARNT in rat male and female reproductive organs and humans will be characterized. Because the AhR and ARNT are highly expressed in oocytes and TCDD can affect preimplantation development, the expression of AhR and ARNT and subsequent receptor-mediated responses following TCDD exposure will be assessed in mouse preimplantation embryos. Finally, the use of AhR and ARNT knockout mice are proposed to determine the role of these receptor proteins in both normal reproductive system and early embryo development, and in mediating TCDD effects on these processes. The results from the proposed studies should contribute to our mechanistic understanding of the reproductive and developmental risks associated with maternal exposure to TCDD and possibly related compounds.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES001332-22
Application #
2518616
Study Section
Toxicology Subcommittee 2 (TOX)
Project Start
1978-06-01
Project End
2000-08-31
Budget Start
1997-09-01
Budget End
1998-08-31
Support Year
22
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Pharmacology
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Hill, Warren G; Zeidel, Mark L; Bjorling, Dale E et al. (2018) The void spot assay: Recommendations on the use of a simple micturition assay for mice. Am J Physiol Renal Physiol :
Wegner, Kyle A; Abler, Lisa L; Oakes, Steven R et al. (2018) Void spot assay procedural optimization and software for rapid and objective quantification of rodent voiding function, including overlapping urine spots. Am J Physiol Renal Physiol 315:F1067-F1080
Cunha, Gerald R; Vezina, Chad M; Isaacson, Dylan et al. (2018) Development of the human prostate. Differentiation 103:24-45
Wegner, Kyle A; Cadena, Mark T; Trevena, Ryan et al. (2017) An immunohistochemical identification key for cell types in adult mouse prostatic and urethral tissue sections. PLoS One 12:e0188413
Moore, Robert W; Fritz, Wayne A; Schneider, Andrew J et al. (2016) 2,3,7,8-Tetrachlorodibenzo-p-dioxin has both pro-carcinogenic and anti-carcinogenic effects on neuroendocrine prostate carcinoma formation in TRAMP mice. Toxicol Appl Pharmacol 305:242-249
Ricke, William A; Lee, Calvin W; Clapper, Tyler R et al. (2016) In Utero and Lactational TCDD Exposure Increases Susceptibility to Lower Urinary Tract Dysfunction in Adulthood. Toxicol Sci 150:429-40
Bauman, Tyler M; Vezina, Chad M; Ricke, Emily A et al. (2016) Expression and colocalization of ?-catenin and lymphoid enhancing factor-1 in prostate cancer progression. Hum Pathol 51:124-33
Keil, Kimberly P; Vezina, Chad M (2015) DNA methylation as a dynamic regulator of development and disease processes: spotlight on the prostate. Epigenomics 7:413-25
Schneider, Andrew J; Moore, Robert W; Branam, Amanda M et al. (2014) In utero exposure to TCDD alters Wnt signaling during mouse prostate development: linking ventral prostate agenesis to downregulated ?-catenin signaling. Toxicol Sci 141:176-87
Schneider, Andrew J; Branam, Amanda M; Peterson, Richard E (2014) Intersection of AHR and Wnt signaling in development, health, and disease. Int J Mol Sci 15:17852-85

Showing the most recent 10 out of 93 publications